Astellas Files Lawsuit Against CV Therapeutics
TOKYO–(BUSINESS WIRE)–Feb 27, 2009 - Astellas US Holding, Inc., a wholly owned subsidiary of Astellas Pharma Inc., today announced that it has filed a lawsuit in the Delaware Chancery Court against CV Therapeutics Inc. (Nasdaq: CVTX) and its…
Amicus Therapeutics Suspends Enrollment for Phase 2 Clinical Trial of AT2220 for Pompe Disease
CRANBURY, N.J., February 27, 2009 /PRNewswire-FirstCall/ — Amicus Therapeutics announced today that the Company has suspended enrollment for the Phase 2 clinical trial of its investigational drug AT2220 (1-deoxynojirimycin HCI) for the treatment of…
Synta Suspends Elesclomol SYMMETRYTrial in Metastatic Melanoma
Analysis by independent DMC identifies safety concerns
Investor Conference Call Scheduled for 5:30 p.m. ET Today
LEXINGTON, Mass.–(BUSINESS WIRE)–Feb 26, 2009 - Synta Pharmaceuticals Corp. (NASDAQ: SNTA), today announced that based on an analysis…
FDA Sends Letter to GlaxoSmithKline Over Avodart Ad
ROCKVILLE, Md., Feb. 26, 2009–The FDA today posted on its website a letter sent to GlaxoSmithKline regarding a DTC TV ad for Avodart. The letter is below.
Michele M. Hardy
Senior Director,
U.S. Regulatory Affairs,
GlaxoSmithKline
P.O. Box…
Endo Pharmaceuticals Returns Product Rights to Transdur-Sufentanil to Durect
CUPERTINO, Calif., February 27, 2009 /PRNewswire-FirstCall/ — DURECT Corporation today reported that Endo Pharmaceuticals has given notice that it is returning to us Endo’s rights in the U.S. and Canada to develop and commercialize…
Metoclopramide-Containing Drugs
Chronic use of metoclopramide has been linked to tardive dyskinesia, which may include involuntary and repetitive movements of the body, even after the drugs are no longer taken.
Possible Case: Metoclopramide
Associated with Development of Movement Disorder
New OnLine System to Provide Canadians with Quicker Access to Safe Natural Health Products
Colin Carrie, Parliamentary Secretary to the Minister of Health, today launched the first phase of Online Solution, a secure online system for processing natural health product submissions, site licences, and clinical trial authorizations for natural health products in Canada.
Parents Learn About HPV Vaccine Mostly from Drug Company Ads
CHAPEL HILL, N.C., Feb 25, 2009, Newswise— Parents and other caretakers of young women learned about human papillomavirus (HPV) vaccine primarily from advertisements sponsored by the pharmaceutical company that makes the vaccine, a…
King Pharmaceuticals Reports Year-End and Fourth-Quarter 2008 Financial Results
2008 Highlights Include Acquisition of Alpharma and Submission of Four New Drug Applications to the FDA
BRISTOL, Tenn.–(BUSINESS WIRE)–Feb 26, 2009 - King Pharmaceuticals, Inc. (NYSE:KG) announced today that total revenues equaled $1.57 billion…